期刊文献+

纳米羟基磷灰石在基因药物载体中的应用 被引量:8

hydroxyapatite nanoparticle as a novel drug or gene carrier
下载PDF
导出
摘要 目的讨论HAP纳米粒子作为药物或基因载体的进展。方法本文主要对HAP纳米粒子作为药物或基因载体的研究现状及他的生物相容性评价作了综述。结果指出了HAP纳米粒子作为药物或基因载体的主要发展趋势及存在的问题。结论药物或基因载体的研究较多,但是尚未找到一种理想的载体材料。作为一种新的药物基因载体,HAP纳米粒子有高的药物吸附量及良好的生物相容性,他有望作为一种新的基因药物载体。 Objective To discuss recent research development about hydroxyapatite nanoparticles as drug or gene carries. Methods This paper overviews the current studies on hydroxyapatite nanoparticles as drug or gene carries evaluation of its biocompatibility. Results To point out the main development tendency ofhydroxyapatite nanoparticles as drug or gene carries. Conclusions Drug or gene carries is a hot subject, but there is still no perfect carries. As a new drug or gene carries hydroxyapatite nanoparticleas have high absorbability and high biocompatibility, which is promising to be used as a novel drug or gene carries.
出处 《生物骨科材料与临床研究》 CAS 2005年第5期40-43,共4页 Orthopaedic Biomechanics Materials and Clinical Study
关键词 羟基磷灰石纳米粒子 药物载体 基因载体 生物相容性 hydroxyapatite nanoparticles drug carries gene carries biocompatibility
  • 相关文献

参考文献5

二级参考文献41

  • 1凌均启,樊明文,彭彬,罗雯,贺红.根管消毒药物控释系统的体外细胞霉性研究[J].口腔医学纵横,1994,10(3):138-140. 被引量:5
  • 2吕晓迎.牙科材料细胞毒性评定的新方法(MTT试验)[J].中华口腔医学杂志,1995,30(6):377-379. 被引量:101
  • 3常津.具有靶向抗癌功能的纳米高分子材料───阿霉素免疫磁性毫微粒的体内磁靶向定位试验[J].中国生物医学工程学报,1996,15(4):354-359. 被引量:32
  • 4Muller RH, Mader K, Gohla S.Solid lipid nanoparticles (SLN)for Controlledolled drug delivery- a review of the state of the art [J].Eur J Pharm Biopharm, 2000, 50 (1): 161-177.
  • 5Sakuma S, Sudo R, Suzuki N, et al.Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine[J].J Controlled Release, 2002, 81 (3): 281-290.
  • 6Cavalli R, Gasco MR, Chetoni P, et al.Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin [J].Int J Pharm, 2002, 238(1-2): 241-245.
  • 7Murakami H, Kobayashi M, Takeuchi H, et al.Utilization of poly (DL-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression [J].J Controlled Release, 2000, 67 (1): 29-36.
  • 8Wissing SA, Muller RH.The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles [J].Int J Pharm, 2002, 242 (1-2): 373-375.
  • 9Ahlin P, Kristl J, Kristl A, et al.Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration [J].IntJPharm, 2002, 239(1-2): 113-120.
  • 10Sharma D, Chelvi TP, Kaur J, et al.Novel taxol formulation:polyvinyl pyrrolidone nanoparticles-encapsulated taxol for drug delivery in cancer therapy [J] Oncol Res, 1996, 8 (7-8): 281-286.

共引文献92

同被引文献137

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部